Mitochondrial disease clinical manifestations: An overview

ABSTRACT: Mitochondrial diseases are a heterogeneous group of disorders that can affect multiple organs with varying severity. Symptoms may be acute or chronic with intermittent decompensation. In childhood-onset disease, there is often a history of global developmental delay, while in adulthood the past history may be unremarkable prior to initial presentation. The unique character of mitochondrial genetics means family history patterns of inheritance may be both maternal and autosomal, making genetic counseling challenging. Tissue specificity and mitochondrial heteroplasmy may result in a spectrum of phenotypes even within a single family with the same molecular defect.


Both pediatric and adult-onset mitochondrial disease can range from mild to severe and can involve more than one organ system.


Mitochondrial diseases are het­er­ogeneous and multifaceted, and can present at any age. Clinical features may range from an acute life-threatening metabolic derangement to intermittent or episodic crises with partial recovery to a more gradual progressive neuro­developmental decline or regression. 

Organ involvement may be isolated but often evolves into multi­system disease. Understanding the general characteristics of pediatric and adult-onset mitochondrial disease and some typical clinical manifestations can allow family physicians to better serve their patients.

General characteristics of pediatric and adult-onset disease
Childhood mitochondrial disease is typically more severe than adult-onset disease and includes progressive neurological, cardiac, and liver dysfunction. In pediatric mitochondrial disease, a broad spectrum of findings may be present, including lethargy, hypotonia, failure to thrive, seizures, cardiomyopathy, deafness, blindness, movement disorder, and lactic acidosis. 

The clinicians’ index of suspicion must remain high when these symptoms are present. Referral to a tertiary care centre for evaluation of a possible mitochondrial disease may originate from all levels of health care and include family practitioners, pediatricians, or subspecialists from medical genetics, neurology, cardiology, endo­crinology, or infant and child development. 

A family history of illness may point toward maternally inherited mitochondrial disease, but the manifestation of the disease may vary tremendously among family members. Diagnosis is often challenging and several algorithms have been proposed specifically to characterize symptoms that may be more prominent in children.[1-5

Adult-onset mitochondrial disease often presents in more subtle ways. The disease may manifest for the first time in adulthood or may be first recognized in adulthood after a history of symptoms dating back to childhood. Adult-onset mitochondrial disease is typically a progressive multisystem disorder. 

Even in patients presenting with symptoms mainly in one organ system (such as myopathy), there is often evidence of multisystem involvement upon physical examination and laboratory evaluation. Although adults with mitochondrial disease may present with findings that are character­istic of a typical syndrome, more commonly they do not. 

Mitochondrial disease should be considered when the characteristic clinical manifestations described below are present and these are accompanied by one or more of the following: (a) involvement of multiple organ systems and/or (b) unusual severity (i.e., early onset with progression over time) and/or (c) maternal inheritance pattern.

Clinical manifestations 
Mitochondrial disease was first des­cribed in the context of patients presenting with recognizable constellations of clinical features that were subsequently shown to be related to genetic defects affecting mitochondrial function. A partial list of these syndromes appears in the accompanying Table.[6] It should be noted, however, that the majority of patients with mitochondrial disease do not present with these easily recognizable features and thus clinicians must have a high index of suspicion when considering the possibility of mitochondrial dysfunction in patients with nonsyndromic presentations, especially those that involve the following systems.

Central nervous system/peripheral nervous system 
Characteristic pediatric manifestations of mitochondrial disease include developmental delay or regression, seizures, and movement disorders.[7,8] Characteristic adult-onset manifestations in­clude stroke or stroke-like episodes. Peripheral neuropathy, which may be symptomatic or only detected on phys­ical examination or through nerve conduction studies, is also a frequent manifestation of mitochondrial diseases.

Visual system and auditory system 
Sensorineural deafness (particularly when onset is early) is a common manifestation of mitochondrial disorders attributable to cochlear dysfunction in combination with dysfunction of cranial nerve VIII.[9,10] Because ocular muscles have the highest density of mitochondria per cell of any type of muscle and thus use a large amount of adenosine triphosphate (ATP), ophthalmological manifestations of mitochondrial disease are common. 

Common eye manifestations due to skeletal muscle involvement include progressive external ophthalmoplegia and ptosis as shown in the ac­companying Figure. The retinal cells may be affected by pigmentary retino­­pathy. The nerve ganglion layer cells are specifically affected by certain mitochondrial diseases resulting in painless sequential loss of visual acuity followed by optic atrophy.

Neuromuscular system
Skeletal muscle manifestations are among the most common manifes­ta­tions of mitochondrial disease.[11] Symp­toms can range from relatively nonspecific exercise intolerance or exercise-induced myalgia to muscle wasting or weakness in a predominantly proximal distribution. All symp­toms are exacerbated by in­flammatory stress so patients may report prolonged recovery times after minor stresses such as illness or general anesthetic. 

Cardiovascular system
Cardiac disease manifestations range from cardiac conduction block to pre­disposition to arrhythmia or de­velopment of Wolff-Parkinson-White syndrome.[12] More severe forms are associated with a metabolic cardio­myopathy, which can be hypertrophic or dilated. 

Gastrointestinal system 
Smooth muscle tissue, the autonomic nervous system, and the enteral neural plexus may all be affected, leading to gastrointestinal tract manifestations, namely those involving disorders of peristalsis.[13-16]

Typical manifestations include delayed gastric emptying with nausea and vomiting, constipation, diarrhea, and intestinal pseudo-obstruc­tion. Fat malabsorption and poor growth due to exocrine pancreatic insufficiency can also occur.

Endocrine system
Endocrine disorders may present in childhood or may develop over time and present in adulthood.[17,18] Diabetes mellitus with a complex pathophysiology can occur. Even though mitochondrial dysfunction inhibits glucose-stimulated insulin secretion, most patients with diabetes related to mitochondrial disease present with a phenotype of type 2 diabetes.

Case examples 
Cases from our pediatric and adult clinics demonstrate how some patients with mitochondrial disease present with nonspecific symptoms, while others present with symptoms of recognizable syndromes.  

Subacute necrotizing encephalopathy (Leigh syndrome)
Leigh syndrome is one of the most severe pediatric manifestations of mito­chondrial disease. 
Patient V-2 in Family A, the family described elsewhere in this theme issue (see pedigree in Figure 1 of “Pri­mer on mitochondrial disease”), was born at term after an unremarkable pregnancy. 

The first concerns in pa­tient V-2 were at 6 months of age, when she was seen to cross her eyes, especially when tired. She was hypotonic and had delayed developmental milestones. She sat at 8 months and didn’t walk until 2 years. 

Her speech was delayed and dysarthric. Ptosis and ophthalmoplegia were observed at 21/2 years of age. Seizures began at 21/2 years with arm stiffness, then clusters of right-sided facial twitching and weakness, then staring spells, eye twitching, and my­oclonic jerks. While ECG and echo­cardiogram results were normal, head MRI showed progressive areas of abnormal T2 hyperintensity in the caudate and lentiform nuclei, and the left frontal lobe. 

Magnetic resonance spectroscopy (MRS) showed intermittent abnormal lactate peaks in the midbrain. Eventually, the patient needed a gastrostomy tube for nutrition and had to use a wheelchair because of progressive weakness. Her condition continued to worsen until she died at 8 years of age.

Cardiomyopathy and conduction defects
Heart-related defects can be presenting features of mitochondrial disease in both adults and children. 
A baby girl was born after an unremarkable prenatal history and birth. However, Apgar scores were low and she required ventilation at birth. She was found to have metabolic acidosis with an elevated lactate of 12 mmol/L (normal < 2.2), and was diagnosed as encephalopathic. 

Brain imaging show­ed delayed myelination but no cortical abnormalities. There was a persistent elevation of lactate peaks in the basal ganglia noted on MRS. Echocardiogram showed marked hypertrophy of all cardiac walls with reduced ejection fraction. 

On day 9 of life she remained encephalopathic with no spontaneous respiratory effort and died upon withdrawal of ventilator support. Heart biopsy showed marked complex IV (cytochrome c oxidase) deficiency inherited via an autosomal recessive genetic syndrome.[18]

Seizures
Seizures can be a presenting feature of mitochondrial disease in both adults and children. When present, seizures may be intractable and associated with a poor prognosis. 

A 10-month-old child presented with focal status epilepticus in association with a viral infection and a normal brain MRI. His development had been previously normal but he subsequently displayed regression in both gross and fine motor skills with hypotonia. 

He had a subsequent episode of status epilepticus at 11 months of age in association with elevated liver enzymes. At 27 months of age he had failure to thrive and presented with abdominal distention, ascites, jaundice, low serum albumin, and elevated lactate. 

Brain MRI showed delayed myelination with normal MRS results. Liver biopsy revealed cirrhosis with no other findings specific for a distinct cause. Molecular testing identified an autosomal recessive disorder in a gene (POLG) associated with Alpers syndrome, a condition of progressive neurological deterioration, intractable seizures, and liver disease. 

This child continued to deteriorate with increasing seizure frequency despite anticonvulsants and died at 3 years of age. 

Visual symptoms
Visual symptoms of mitochondrial disease can be related to problems with the optic nerve, retinal dysfunction, or eye movement.

A 34-year-old woman was investigated by an ophthamologist for mild ptosis and was found to have chronic progressive external ophthalmoplegia (CPEO). She reported a 20-year his­tory of diplopia related to fatigue. She was referred to a neurologist who noted mild weakness in her deltoid, bicep, and neck flexor muscles. A muscle biopsy revealed a deletion in mitochondrial DNA, confirming the diagnosis of mitochondrial CPEO. 

Stroke and stroke-like episodes
Stroke and stroke-like episodes (ischem­ic necrosis of brain tissue occuring in the absence of vascular occlusion) are a unique feature of mitochondrial disease. 

A stable patient with longstanding sensorineural hearing loss and well-controlled type 2 diabetes presented acutely with bilateral strokes affecting the basal ganglia. There was a maternal inheritance pattern for the deafness and diabetes. 

The consulting geneticist recognized the association of maternally inherited diabetes, deafness, and stroke-like episodes as characteristic of the MELAS syndrome. Diagnostic tests confirmed the clinical impression. This gentleman had several typical features of stroke associated with mitochondrial disease: 

• Relatively young age (mid-40s). 
• Extraneurologic features of mitochondrial disease (diabetes, sensor­ineural hearing loss).
• No other cause of stroke identified (e.g., no source of cardiac emboli or cerebral atherosclerosis). 
• Presence of a stroke in a region of the brain that does not conform to regions of vascular distribution (bilateral basal ganglia infarction). 

Exertional myalgia
Exertional myalgia is a common presenting symptom of mitochondrial disease, especially in adults. 
A 40-year-old man presented with exertional myalgias dating back to the age of 14. He experienced fatigue with even minor activities such as walking up a flight of stairs, holding a clipboard, and filling a coffee pot with water. 

Clinical history revealed type 2 diabetes and progressive dysphagia. A muscle biopsy done at the time of a Heller esophagomyotomy for the dysphagia (caused by a hypertensive lower esophageal sphincter) revealed subsarcolemmal accumulation of mi­to­chondria and cytochrome oxidase negative muscle fibres, confirming the diagnosis of mitochondrial myo­pathy.
 
Conclusions
Mitochondrial diseases can present at any age and with symptoms in any organ system, including the central nervous system, visual system, and neuromuscular system. Neurological manifestations include encephalopathy, cognitive regression, seizures, and peripheral neuropathy. 

Involvement of skeletal and cardiac muscle is frequent, while endocrine system mani­festations commonly include diabetes mellitus. 

Multisystem involvement is a clue to the diagnosis of possible mitochondrial disease in patients who present with nonspecific symptoms. Referral to a tertiary care centre should be considered when a family practitioner, pediatrician, or subspecialist suspects maternally inherited disease.

Competing interests
None declared.


References

1. Wolf NI, Smeitink JA. Mitochondrial disorders: A proposal for consensus diagnostic criteria in infants and children. Neurology 2002;59:1402-1405. PubMed Abstract.
2. Bernier FP, Boneh A, Dennett X, et al. Diagnostic criteria for respiratory chain disorders in adults and children. Neurology 2002;59:1406-1411. PubMed Abstract.
3. Morava E, van den Heuvel L, Hol F, et al. Mitochondrial disease criteria: Diagnostic applications in children. Neurology 2006;67:1823-1826. PubMed Abstract.
4. Gropman AL. Diagnosis and treatment of childhood mitochondrial diseases. Curr Neurol Neurosci Rep 2001;1:185-194. PubMed Abstract.
5. Kisler JE, Whittaker RG, McFarland R. Mitochondrial diseases in childhood: A clinical approach to investigation and management. Dev Med Child Neurol 2010;52:422-433. PubMed Abstract.
6. Pestronk A. Mitochondrial disorders. Neuromuscular Disease Center website. St Louis, MO: Washington University. Accessed 7 March 2011. http://neuromuscular.wustl.edu/mitosyn.html
7. Finsterer J. Central nervous system imaging in mitochondrial disorders. Can J Neurol Sci 2009;36:143-153.
PubMed Abstract.
8. Finsterer J. Mitochondrial neuropathy. Clin Neurol Neurosurg 2005;107:181-186. PubMed Abstract.
9. Gronlund MA, Honarvar AK, Andersson S, et al. Ophthalmological findings in children and young adults with genetically verified mitochondrial disease. Br J Ophthalmol 2010;94:121-127. PubMed Abstract.
10. Yu Wai Man CY, Chinnery PF, Griffiths PG. Extraocular muscles have fundamentally distinct properties that make them selectively vulnerable to certain disorders. Neuromuscul Disord 2005;15:17-23. PubMed Abstract.
11. van Adel BA, Tarnopolsky MA. Metabolic myopathies: Update 2009. J Clin Neuromuscul Dis 2009;10:97-121. PubMed Abstract.
12. Wahbi K, Larue S, Jardel C, et al. Cardiac involvement is frequent in patients with the m.8344A>G mutation of mitochondrial DNA. Neurology 2010;74:674-677. PubMed Abstract.
13. Parsons T, Weimer L, Engelstad K, et al. Autonomic symptoms in carriers of the m.3243A>G mitochondrial DNA mutation. Arch Neurol 2010;67:976-979. PubMed Abstract.
14. Amiot A, Tchikviladze M, Joly F, et al. Frequency of mitochondrial defects in patients with chronic intestinal pseudo-obstruction. Gastroenterology 2009;137:101-109. PubMed Abstract.
15. Blondon H, Polivka M, Joly F, et al. Digestive smooth muscle mitochondrial myopathy in patients with mitochondrial-neuro-gastro-intestinal encephalomyopathy (MNGIE). Gastroenterol Clin Biol 2005;29:773-778. PubMed Abstract.
16. Schiff M, Loublier S, Coulibaly A, et al. Mitochondria and diabetes mellitus: Untangling a conflictive relationship? J Inherit Metab Dis 2009;32:684-698. PubMed Abstract.
17. Szendroedi J, Schmid AI, Meyerspeer M, et al. Impaired mitochondrial function and insulin resistance of skeletal muscle in mitochondrial diabetes. Diabetes Care 2009;32:677-679. PubMed Abstract.
18. Alfadhel M, Lillquist YP, Waters PJ, et al. Infantile cardioencephalopathy due to a COX15 gene defect: Report and review. Am J Med Genet A 2011 Mar 15. doi: 10.1002/ajmg.a.33881. PubMed Abstract.


This article has been peer reviewed.
Dr Mattman is a consultant at the Adult Metabolic Diseases Clinic with a particular interest in the care of patients with mitochondrial disease. He is also a clinical assistant professor in the Department of Pathology and Laboratory Medicine at UBC. Dr Sirrs is medical director of the Adult Metabolic Diseases Clinic at Vancouver General Hospital. She is also a clinical associate professor in the Division of Endocrinology at UBC. Dr Mezei is a consultant neurologist at the Adult Metabolic Diseases Clinic and Neuromuscular Diseases Unit at Vancouver General Hospital, and a clinical assistant professor in the Division of Neurology at the University of British Columbia. Dr Salvarinova-Zivkovic is a clinician in the Division of Biochemical Diseases at the BC Children’s Hospital and is a clinical assistant professor in the Department of Pediatrics at UBC. Dr Alfadhel is a clinical fellow training in the Biochemical Clinical Disease service at BC Children’s Hospital. Dr Lill­quist is a pediatrician in the Division of Biochemical Diseases at BC Children’s Hospital and clinical assistant professor in the Department of Pediatrics at UBC.

Andre Mattman, MD, FRCPC, Sandra Sirrs, MD, FRCPC,, Michelle M. Mezei, MDCM, FRCPC,, Ramona Salvarinova-Zivkovic, MD, FRCPC, FCCMG,, Majid Alfadhel, MHSc, MD, FCCMG,, Yolanda Lillquist, MD, FRCPC,. Mitochondrial disease clinical manifestations: An overview. BCMJ, Vol. 53, No. 4, May, 2011, Page(s) 183-187 - Clinical Articles.



Above is the information needed to cite this article in your paper or presentation. The International Committee of Medical Journal Editors (ICMJE) recommends the following citation style, which is the now nearly universally accepted citation style for scientific papers:
Halpern SD, Ubel PA, Caplan AL, Marion DW, Palmer AM, Schiding JK, et al. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347:284-7.

About the ICMJE and citation styles

The ICMJE is small group of editors of general medical journals who first met informally in Vancouver, British Columbia, in 1978 to establish guidelines for the format of manuscripts submitted to their journals. The group became known as the Vancouver Group. Its requirements for manuscripts, including formats for bibliographic references developed by the U.S. National Library of Medicine (NLM), were first published in 1979. The Vancouver Group expanded and evolved into the International Committee of Medical Journal Editors (ICMJE), which meets annually. The ICMJE created the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals to help authors and editors create and distribute accurate, clear, easily accessible reports of biomedical studies.

An alternate version of ICMJE style is to additionally list the month an issue number, but since most journals use continuous pagination, the shorter form provides sufficient information to locate the reference. The NLM now lists all authors.

BCMJ standard citation style is a slight modification of the ICMJE/NLM style, as follows:

  • Only the first three authors are listed, followed by "et al."
  • There is no period after the journal name.
  • Page numbers are not abbreviated.


For more information on the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, visit www.icmje.org

BCMJ Guidelines for Authors

Leave a Reply